Accumulating evidence highlighted that KLF2 may be regulated by lncRNAs such as FBXL10-AS1 and GHET1, thus affecting HCC progression [60–64], and that KLF2 can mediate HCC progression through c-myc [65]. This evidence concerns the gene KDM2B and hepatocellular carcinoma.